Breast cancer regulates the expression of human epidermal growth factor receptor-2 (HER-2), which is further characterized by its high invasiveness, unfavorable clinical outcomes, and elevated likelihood of recurrence. The gene discussed is ERBB2; the disease is breast carcinoma.